Physician profile
Asha Gowda
NPI 1982100293
$4,374.97
in general payments reported to CMS, 2019-2025
16 companies · $1,425 in 2025
The $1,425 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $98.64 · 2021: $160 · 2022: $702 · 2023: $1,344 · 2024: $408 · 2025: $1,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,296 · Travel and Lodging: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,296.32 |
| Travel and Lodging | $881.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,406.54 | 2023-2025 | |
| Genzyme Corporation | $852.52 | 2019-2024 | |
| Janssen Biotech, INC. | $398.35 | 2021-2025 | Tremfya |
| Galderma Laboratories, L.P. | $300.84 | 2019-2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.95 | 2022-2023 | |
| Ucb, INC. | $242.13 | 2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $212.39 | 2024-2025 | Sotyktu |
| Janssen Scientific Affairs, LLC | $138.06 | 2022 | |
| Novartis Pharmaceuticals Corporation | $132.00 | 2022-2025 | |
| Lilly USA, LLC | $130.03 | 2019-2025 | Taltz, Ebglyss |
| Blueprint Medicines Corporation | $103.73 | 2025 | |
| Incyte Corporation | $82.23 | 2025 | Opzelura, Opzelura |
| Strata Skin Sciences, INC. | $42.49 | 2024-2025 | Xtrac |
| Arcutis Biotherapeutics, INC. | $35.52 | 2025 | Zoryve |
| Amgen INC. | $30.46 | 2025 | Otezla |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $17.73 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Gowda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.